Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC)
Condition: Prostatic Cancer, Castration-Resistant Interventions: Drug: Darolutamide(Nubeqa, BAY1841788); Drug: Enzalutamide Sponsor: Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials